Skip to main content
Log in

Population Pharmacokinetics of Combined Intravenous and Local Intrathecal Administration of Meropenem in Aneurysm Patients with Suspected Intracranial Infections After Craniotomy

  • Original Research Article
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Abstract

Background and Objective

For patients with intracranial infection, local intrathecal administration of meropenem may be a useful method to obtain a sufficient drug concentration in the cerebral spinal fluid (CSF). However, a large inter-individual variability may pose treatment efficacy at risk. This study aimed to identify factors affecting drug concentration in the CSF using population pharmacokinetics method.

Methods

After craniotomy, aneurysm patients with an indwelling lumbar cistern drainage tube who received a combined intravenous and intrathecal administration of meropenem for the treatment of suspected intracranial infection were enrolled. Venous blood and CSF specimens were collected for determining meropenem concentrations. Nonlinear mixed-effects modeling method was used to fit blood and CSF concentrations simultaneously and to develop the population pharmacokinetic model. The proposed model was applied to simulate dosage regimens.

Results

A three-compartmental model was established to describe meropenem in vivo behavior. Lumbar CSF drainage resulted in a drug loss, and drug clearance in CSF (CLCSF) was employed to describe this. The covariate analysis found that the drainage volume (mL/day) was strongly associated with CLCSF, and the effect of creatinine clearance was significant on the clearance of meropenem in blood (CL). Visual predictive check suggested that the proposed pharmacokinetic model agreed well with the observations. Simulation showed that both intravenous and intrathecal doses should be increased with the increases of minimum inhibitory concentration and daily CSF drainage volume.

Conclusion

This model incorporates covariates of the creatinine clearance and the drainage volume, and a simple to use dosage regimen table was created to guide clinicians with meropenem dosing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. National Nosocomial Infections Surveillance S. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–85.

    Article  Google Scholar 

  2. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267–84.

    Article  PubMed  Google Scholar 

  3. Beer R, Lackner P, Pfausler B, Schmutzhard E. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol. 2008;255:1617–24.

    Article  CAS  PubMed  Google Scholar 

  4. Rifi L, Barkat A, El Khamlichi A, Boulaadas M, El Ouahabi A. Neurosurgical management of anterior meningo-encephaloceles about 60 cases. Pan Afr Med J. 2015;21:215.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Zolal A, Juratli T, Dengl M, Ficici KH, Schackert G, Sobottka SB. Daily drained CSF volume is a predictor for shunt dependence—a retrospective study. Clin Neurol Neurosurg. 2015;138:147–50.

    Article  PubMed  Google Scholar 

  6. Al-Tamimi YZ, Bhargava D, Feltbower RG, Hall G, Goddard AJ, Quinn AC, et al. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage: a prospective, randomized, controlled trial (LUMAS). Stroke. 2012;43:677–82.

    Article  PubMed  Google Scholar 

  7. Park S, Yang N, Seo E. The effectiveness of lumbar cerebrospinal fluid drainage to reduce the cerebral vasospasm after surgical clipping for aneurysmal subarachnoid hemorrhage. J Korean Neurosurg Soc. 2015;57:167–73.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Li X, Wu Y, Sun S, Mei S, Wang J, Wang Q, et al. Population pharmacokinetics of vancomycin in postoperative neurosurgical patients. J Pharm Sci. 2015;104:3960–7.

    Article  CAS  PubMed  Google Scholar 

  9. Chen K, Wu Y, Wang Q, Wang J, Li X, Zhao Z, et al. The methodology and pharmacokinetics study of intraventricular administration of vancomycin in patients with intracranial infections after craniotomy. J Crit Care. 2015;30(218):e1–5.

    Google Scholar 

  10. Gutierrez J, Federici T, Peterson B, Bartus R, Betourne A, Boulis NM. Development of intrathecal riluzole: a new route of administration for the treatment of amyotrophic lateral sclerosis patients. Neurosurgery. 2016;63(Suppl 1):193.

    Article  PubMed  Google Scholar 

  11. Mei S, Luo X, Li X, Li Q, Huo J, Yang L, et al. Development and validation of an LC-MS/MS method for the determination of tigecycline in human plasma and cerebrospinal fluid and its application to a pharmacokinetic study. Biomed Chromatogr. 2016;30:1992–2002.

    Article  CAS  PubMed  Google Scholar 

  12. Blassmann U, Roehr AC, Frey OR, Vetter-Kerkhoff C, Thon N, Hope W, et al. Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study. Crit Care. 2016;20:343.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Zhang Y, Zhang J, Chen Y, Yu J, Cao G, Wu X, et al. Evaluation of meropenem penetration into cerebrospinal fluid in patients with meningitis after neurosurgery. World Neurosurg. 2017;98:525–31.

    Article  PubMed  Google Scholar 

  14. Roth T, Fiedler S, Mihai S, Parsch H. Determination of meropenem levels in human serum by high-performance liquid chromatography with ultraviolet detection. Biomed Chromatogr. 2017. doi:10.1002/bmc.3880.

  15. Li X, Wu Y, Sun S, Zhao Z, Wang Q. Population pharmacokinetics of vancomycin in postoperative neurosurgical patients and the application in dosing recommendation. J Pharm Sci. 2016;105:3425–31.

    Article  CAS  PubMed  Google Scholar 

  16. Lu C, Zhang Y, Chen M, Zhong P, Chen Y, Yu J, et al. Population pharmacokinetics and dosing regimen optimization of meropenem in cerebrospinal fluid and plasma in patients with meningitis after neurosurgery. Antimicrob Agents Chemother. 2016;60:6619–25.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Lodise TP, Nau R, Kinzig M, Drusano GL, Jones RN, Sorgel F. Pharmacodynamics of ceftazidime and meropenem in cerebrospinal fluid: results of population pharmacokinetic modelling and Monte Carlo simulation. J Antimicrob Chemother. 2007;60:1038–44.

    Article  CAS  PubMed  Google Scholar 

  18. Li C, Kuti JL, Nightingale CH, Nicolau DP. Population pharmacokinetic analysis and dosing regimen optimization of meropenem in adult patients. J Clin Pharmacol. 2006;46:1171–8.

    Article  CAS  PubMed  Google Scholar 

  19. Chung EK, Cheatham SC, Fleming MR, Healy DP, Kays MB. Population pharmacokinetics and pharmacodynamics of meropenem in nonobese, obese, and morbidly obese patients. J Clin Pharmacol. 2017;57:356–68.

    Article  CAS  PubMed  Google Scholar 

  20. Usman M, Frey OR, Hempel G. Population pharmacokinetics of meropenem in elderly patients: dosing simulations based on renal function. Eur J Clin Pharmacol. 2017;73:333–42.

    Article  CAS  PubMed  Google Scholar 

  21. Xu Q, Yu SB, Zheng N, Yuan XY, Chi YY, Liu C, et al. Head movement, an important contributor to human cerebrospinal fluid circulation. Sci Rep. 2016;6:31787.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank Dr. Yuanxing Wu and Dr. Guangqiang Chen for their help with sample collection.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhigang Zhao.

Ethics declarations

Funding

This work was supported by Grants from the National Natural Science Foundation of China (81503157), the Organization Department of Beijing Municipal Committee (2014000021469G258), and the Capital Medical University (16JL72).

Conflicts of interest

XL, SS, QW and ZZ have no conflict of interest to declare.

Ethics approval

All procedures in this study were in accordance with the 2008 Declaration of Helsinki and ICH Guideline for Good Clinical Practice. This protocol was approved by the Institutional Review Board of Beijing Tiantan Hospital, Capital Medical University (ID: KY2014-014-02).

Informed consent

Written informed consents from all patients or their healthcare surrogates were obtained.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, X., Sun, S., Wang, Q. et al. Population Pharmacokinetics of Combined Intravenous and Local Intrathecal Administration of Meropenem in Aneurysm Patients with Suspected Intracranial Infections After Craniotomy. Eur J Drug Metab Pharmacokinet 43, 45–53 (2018). https://doi.org/10.1007/s13318-017-0422-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13318-017-0422-1

Navigation